Valor Medical's Neucrylate AN device receives CE Mark approval for treating cerebral aneurysms

Download PDF Copy

May 12 2011

Valor Medical announced today that it has received CE Mark approval for Neucrylate AN for treating cerebral aneurysms.

Neucrylate AN is a liquid embolic device that is injected through a microinfusion catheter into the aneurysm. When Neucrylate AN comes in contact with the blood in the aneurysm it immediately changes from a liquid into a porous, elastic, sponge like material. Unlike conventional micro-coils used for treating cerebral aneurysms Neucrylate AN fills the entire aneurysm – regardless of its size or shape.

Charles Kerber, M.D., founder and Chief Medical Officer stated, "Neucrylate AN will be another tool for treating cerebral aneurysms, especially those with wide necks and the larger aneurysms of complicated shape. During the clinical trials the time to treat patients was reduced from hours to minutes, which should increase the surgery's safety, and certainly decreased the radiation dose."

"The CE Mark approval for Neucrylate AN in Europe is a major accomplishment for Valor Medical. We look forward to beginning commercialization activities and will begin training physicians next month in Budapest, Hungary," said H. Clark Adams, Chief Executive Officer

Source:

Valor Medical

Posted in: Device / Technology News | Medical Condition News

Comments (0)

Download PDF Copy

Suggested Reading

Ablation methods equally effective for drug-resistant paroxysmal atrial fibrillation

Triglycerides identified as direct cause of abdominal aortic aneurysms

Elevated TMAO levels linked to higher risk of abdominal aortic aneurysms

Longitudinal study reveals how GLP-2 analog therapy transforms the intestinal environment

New studies highlight disparities and progress in stroke treatment access

Novel ablation approach improves outcomes in patients with persistent atrial fibrillation

Novel vascularized cancer-on-a-chip model reflects the microenvironment of liver tumors

Deadly central line-associated bloodstream infections could be prevented using new e-catheter hub

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.